Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ctDNA Testing in Resectable Stage II-IV Colorectal Cancer Patients: A Head-to-Head Performance Comparison

NCT07125729 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT07125729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07125729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ctDNA Testing in Resectable Stage II-IV Colorectal Cancer Patients: A Head-to-Head Performance Comparison
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
August 29, 2025
Completion date
January 9, 2028
Enrollment
150 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

resectable colorectal carcinoma, stage ii colorectal cancer ajcc v8, stage iii colorectal cancer ajcc v8, stage iv colorectal cancer ajcc v8